Stockreport

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease [Yahoo! Finance]

Alpha Cognition Inc.  (ACOG) 
PDF All launch activities delivered on-time and on-budget, positioning ZUNVEYL for success VANCOUVER, British Columbia & DALLAS, March 18, 2025 BUSINESS WIRE )--Alpha Cog [Read more]